OncoLife - Myeloma Panel

 OncoLife - Myeloma Panel

Detect. Characterize. Personalize Myeloma Treatment.

The OncoLife - Myeloma Panel is an advanced genomic profiling test designed to identify clinically significant genetic alterations associated with multiple myeloma. Using next-generation sequencing (NGS), the panel helps oncologists make informed decisions regarding diagnosis, prognosis, targeted therapy selection, and disease monitoring.

Why is this test done?

• Supports accurate molecular characterization of multiple myeloma
• Identifies actionable genetic mutations linked to targeted therapies
• Assists in risk stratification and prognosis
• Helps guide personalized treatment decisions
• Can support disease monitoring and therapy planning

Who should consider this test?

• Patients newly diagnosed with multiple myeloma
• Individuals with relapsed or refractory myeloma
• Patients being evaluated for targeted or precision oncology treatments
• Cases requiring comprehensive genomic assessment

Sample Required

• Bone marrow aspirate or other clinically appropriate specimen (as advised by the treating oncologist).

Why choose Advanced BioCare Laboratories?

• Advanced NGS-based cancer diagnostics
• High-quality, accurate molecular analysis
• Fast and reliable reporting
• Expert support for precision oncology testing

Advanced insights for personalized myeloma care.